Acceptance and Commitment Therapy (DNA-V)
OtherFamily-Centred ACT for ABI will begin with a needs assessment and comprise needs- and ABI-specific psychoeducation and ACT principles using the DNA-V model of ACT.
NCT Number: NCT07303075
Children and young people with acquired brain injury (ABI) commonly experience long-term emotional, behavioural, and participation difficulties that can affect quality of life for both them and their families. Parents and caregivers also often experience high levels of stress and reduced wellbeing. Despite these needs, family-centred psychological interventions remain limited. Acceptance and Commitment Therapy (ACT) is a values-focused cognitive-behavioural approach designed to increase psychological flexibility and has shown promise for children with long-term health conditions and for parents of children with ABI, but it has not been directly evaluated as a joint therapeutic approach for children with ABI and their parents.
This study (Family CARE-ABI) evaluates the feasibility, acceptability, and preliminary effectiveness of delivering ACT simultaneously to a young person aged 11-18 with an ABI and their parent/guardian. Up to six dyads will be recruited. The study uses a non-concurrent, multiple-baseline, single-case experimental design in which dyads are randomised to begin a 12-week ACT intervention after either a 3- or 4-week baseline period. Sessions (up to 12, one hour each) are delivered via Microsoft Teams by a trainee clinical psychologist under specialist supervision. Therapy integrates the DNA-V model of ACT-developed for young people-with ABI-specific psychoeducation and skills practice tailored to each dyad's needs.
Outcome measures include mental health and wellbeing (Outcome Rating Scale), psychological flexibility (CompACT or AFQ-Y8), symptoms of anxiety and depression (GAD-7, PHQ-9, or RCADS-25), community participation (CASP/CASP-Y), and needs after ABI (MANTIC). Measures are collected at baseline, post-intervention, and 12-week follow-up, with weekly wellbeing ratings throughout participation. Therapeutic alliance (SRS) is obtained after each intervention session. All dyads will also take part in separate qualitative interviews exploring their experiences of the intervention and its impact.
Safety is closely monitored, including assessment of distress, adverse events, and any safeguarding concerns. Participation is voluntary, and dyads may withdraw at any time without affecting usual care. Data are stored securely and anonymised for analysis.
The study aims to generate early evidence regarding whether family-centred ACT may support psychological wellbeing, flexibility, and participation for young people with ABI and their parents, and to inform future intervention development and larger-scale trials.
Trial opening soon.
Get Notified11 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Both the CYP-ABI and parent participants must meet the inclusion criteria to be recruited to the study.
CYP-ABI participant inclusion criteria include:
Parent participant inclusion criteria include:
Exclusion criteria
CYP-ABI and parent participant exclusion criteria include:
Family-Centred ACT for ABI will begin with a needs assessment and comprise needs- and ABI-specific psychoeducation and ACT principles using the DNA-V model of ACT.
Time frame: From enrollment to the end of the study at 24 weeks
Measure of wellbeing
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of psychological flexibility for adults
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of psychological flexibility for children
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measures of adult anxiety and depression
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of child anxiety and depression
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of child participation
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of needs after acquired brain injury
Time frame: Baseline (week 1), following therapy (week 15 or 16), at follow-up (week 24)
Measure of therapeutic alliance
University of Nottingham
Other
Family-Centred Acceptance and Commitment Therapy After Paediatric Acquired Brain Injury
Acronym: FamilyCARE-ABI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07600320
Acquired Brain Injury, Alzheimer Disease
New York, United States
View Trial DetailsNCT05897593
Acquired Brain Injury, Brain Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT06343415
Acquired Brain Injury, Brain Diseases
Glostrup Municipality, Greater Copenhagen, Denmark
View Trial DetailsNCT06840808
Acquired Brain Injury, Anomia
Richardson, Texas, United States
View Trial Details